What does Basil Systems do?
Basil Systems delivers an AI-powered product lifecycle intelligence platform that helps pharma and MedTech companies manage regulatory, clinical, and product lifecycle strategy by structuring indexed databases of regulatory, drug, device, and post-market data.
How much did they raise?
The company raised $11.5M in funding, with the round led by Golden Ventures and participation from Hearst Ventures and Argosy Capital.
What are their plans for the money?
Basil Systems plans to use the funds to expand its enterprise BasilIntel SaaS platform, enhance its product capabilities, and accelerate the integration of data-driven insights across the pharma and medical device industries.
What have they achieved so far?
The company has already made significant progress by establishing a unified system of record and intelligence used for strategic product development, supply chain optimization, risk mitigation, and real-world evidence analysis.
